Prism reports revenue increase
TORONTO – Prism Medical announced revenues of $14.7 million for the first quarter ended Feb. 29, 2016, an increase of 20% compared to the same period last year. Adjusted EBITDA was $1.5 million. The company says government funding for its products in Canada is a key driver of sales. Prism also believes that the U.S. market holds the greatest long-term potential for revenue growth in both the home care and institutional markets.